Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Kidney Int ; 71(12): 1262-70, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17410101

RESUMO

Hyperphosphatemia is a driving force in the pathogenesis of vascular calcification (VC) and secondary hyperparathyroidism associated with renal failure. To test for the possible contribution of parathyroid hormone (PTH) to cardiovascular calcification, we removed the parathyroid glands from rats but infused synthetic hormone at a supraphysiologic rate. All rats were pair-fed low, normal, or high phosphorus diets and subjected to a sham or 5/6 nephrectomy (remnant kidney). Control rats were given a normal diet and underwent both sham parathyroidectomy and 5/6 nephrectomy. Heart weight/body weight ratios and serum creatinine levels were higher in remnant kidney rats than in the sham-operated rats. Remnant kidney rats on the high phosphorus diet and PTH replacement developed hyperphosphatemia and hypocalcemia along with low bone trabecular volume. Remnant kidney rats on the low phosphorus diet or intact kidney rats on a normal phosphorus diet, each with hormone replacement, developed hypercalcemia. All rats on PTH replacement developed intense aortic medial calcification, and some animals presented coronary calcification. We suggest that high PTH levels induce high bone turnover and medial calcification resembling Mömckeberg's sclerosis independent of uremia. This model may be useful in defining mechanisms underlying VC.


Assuntos
Calcinose/complicações , Doenças Cardiovasculares/complicações , Modelos Animais de Doenças , Hormônio Paratireóideo/fisiologia , Ratos , Insuficiência Renal/etiologia , Animais , Aorta/patologia , Peso Corporal/efeitos dos fármacos , Remodelação Óssea , Calcinose/metabolismo , Calcinose/patologia , Doenças Cardiovasculares/metabolismo , Doenças Cardiovasculares/patologia , Vasos Coronários/patologia , Ingestão de Alimentos/efeitos dos fármacos , Hipercalcemia/etiologia , Masculino , Hormônio Paratireóideo/farmacologia , Pletismografia , Ratos Wistar
2.
Braz J Med Biol Res ; 27(3): 655-61, 1994 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8081290

RESUMO

Administration of methylmalonic acid in rats has been used as a model for methylmalonicacidemia in humans. Nestling Wistar rats of both sexes received 5 injections daily at 3-h intervals (starting at 7:30 a.m.) of saline or methylmalonic acid (MMA, 10 mg/ml) in a volume of 9 microliters/g body weight per injection subcutaneously in the lumbar region from the 5th to the 9th day of life and 11 microliters/g from day 10 to 14. Growth and neuromotor development were assessed by monitoring the following parameters daily in 54 rats: body weight, ear unfolding, incisor eruption, eye opening, righting, palmar grasp, negative geotaxis, cliff avoidance, free-fall righting and startle reflex. The only statistically significant effects of MMA administration were on the day of appearance of the free-fall righting reflex: MMA, 12.44 +/- 1.55 vs 11.0 +/- 0.39 days for saline control (P < 0.05, by two-way ANOVA) and a significant decrease in weight (P < 0.05, by ANOVA with repeated measures). The results suggest that chronic MMA administration to rats has a selective effect on neuromotor development.


Assuntos
Comportamento Animal/efeitos dos fármacos , Ácido Metilmalônico/farmacologia , Animais , Peso Corporal/efeitos dos fármacos , Feminino , Crescimento/efeitos dos fármacos , Masculino , Ácido Metilmalônico/administração & dosagem , Atividade Motora/efeitos dos fármacos , Ratos , Ratos Wistar , Reflexo/efeitos dos fármacos , Fatores de Tempo
3.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;27(3): 655-61, Mar. 1994. tab, graf
Artigo em Inglês | LILACS | ID: lil-148938

RESUMO

Administration of methylmalonic acid in rats has been used as a model for methylmalonicacidemia in humans. Nestling Wistar rats of both sexes received 5 injections daily at 3-h intervals (starting at 7:30 a.m.) of saline or methylmalonic acid (MMA, 10 mg/ml) in a volume of 9 microliters/g body weight per injection subcutaneously in the lumbar region from the 5th to the 9th day of life and 11 microliters/g from day 10 to 14. Growth and neuromotor development were assessed by monitoring the following parameters daily in 54 rats: body weight, ear unfolding, incisor eruption, eye opening, righting, palmar grasp, negative geotaxis, cliff avoidance, free-fall righting and startle reflex. The only statistically significant effects of MMA administration were on the day of appearance of the free-fall righting reflex: MMA, 12.44 +/- 1.55 vs 11.0 +/- 0.39 days for saline control (P < 0.05, by two-way ANOVA) and a significant decrease in weight (P < 0.05, by ANOVA with repeated measures). The results suggest that chronic MMA administration to rats has a selective effect on neuromotor development


Assuntos
Animais , Masculino , Feminino , Ratos , Ácido Metilmalônico/farmacologia , Comportamento Animal/efeitos dos fármacos , Ácido Metilmalônico/administração & dosagem , Peso Corporal/efeitos dos fármacos , Crescimento/efeitos dos fármacos , Atividade Motora/efeitos dos fármacos , Ratos Wistar , Reflexo/efeitos dos fármacos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA